Should laboratories test methicillin-resistant Staphylococcus aureus for elevated vancomycin minimum inhibitory concentrations by etest as a driver of treatment changes?

Clinical Infectious Diseases

Volumn 55, Issue 4, 2012, Pages 612-613

  Humphries, Romney M ^a   Hindler, Janet A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; DAPTOMYCIN; VANCOMYCIN;

ACCURACY; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; EPSILOMETER TEST; HUMAN; LABORATORY TEST; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84864439400     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis469     Document Type: Letter

References (14)

1. van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 2012; 54: 755-71.
2. Swenson JM, Anderson KF, Lonsway DR, et al. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus. J Clin Microbiol 2009; 47:2013-7.
3. Prakash V, Lewis JS, Jorgensen JH. Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother 2008; 52:4528.
4. Martin C. Heterogeneity of brain heart infusion agar media (BHI): effects on the determination of the vancomycin and the teicoplanin minimal inhibitory concentrations (MIC) of Staphylococcus aureus strains. Pathol Biol 2004; 52:450-4.
5. Huang WC, Lee CH, Liu JW. Clinical characteristics and risk factors for mortality in patients with meningitis caused by Staphylococcus aureus and vancomycin minimal inhibitory concentrations against these isolates. J Microbiol Immunol Infect 2010; 43:470-7.
6. Lodise TP, Graves J, Evans A, et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008; 52:3315-20.
7. Lalueza A, Chaves F, San Juan R, Daskalaki M, Otero JR, Aguado JM. Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillinresistant Staphylococcus aureus bacteremia? J Infect Dis 2010; 201:311-2; author reply 2-3.
8. Soriano A, Marco F, Martinez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin- resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46:193-200.
9. Takesue Y, Nakajima K, Takahashi Y, et al. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/mL methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia. J Infect Chemother 2011; 17:52-7.
10. Hsu DI, Hidayat LK, Quist R, et al. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of methicillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 2008; 32:378-85.
11. Edwards B, Milne K, Lawes T, Cook I, Robb AGould IM. Is vancomycin MIC μCreepμ method dependent? Analysis of methicillinresistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010. J Clin Microbiol 2012; 50:318-25.
12. Sader HS, Rhomberg PR, Jones RN. Ninehospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillinresistant Staphylococcus aureus. Antimicrob Agents Chemother 2009; 53:3162-5.
13. Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a casecontrol study. Clin Infect Dis 2012; 54: 51-8.
14. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children: executive